Scroll To Top


2019 08/27

Pharma Boardroom Feature

The CEO of Instant NanoBiosensors, Tony Chung, was recently interviewed by Pharma Boardroom to talk about the potential of the FOPPR technology, the commercialization strategy of the Biomarker Analyzer INB-D200, and the advantages of being a Taiwanese diagnostics device startup!

Interview feature:

Back List